Chao, Ariana M.

Sex/gender differences in obesity prevalence, comorbidities, and treatment

Cooper, A. J., Gupta, S. R., Moustafa, A. F., & Chao, A. M. (2021) · Current Obesity Reports

Obesity, Physical Activity, DietObesity and Health Practices

Cited by 483

Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial

Wadden, T. A., Chao, A. M., Machineni, S., Kushner, R., Ard, J., Srivastava, G., Halpern, B., Zhang, S., Chen, J., Bunck, M. C., et al. (2023) · Nature Medicine

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 442

Dietary interventions for obesity: clinical and mechanistic findings.

Chao, A. M., Quigley, K. M., & Wadden, T. A. (2021) · Journal of Clinical Investigation

Diet and metabolism studiesDietary Effects on Health

Cited by 257

Semaglutide for the treatment of obesity

Chao, A. M., Tronieri, J. S., Amaro, A., & Wadden, T. A. (2023) · Trends in Cardiovascular Medicine

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 227

The Role of Lifestyle Modification with Second-Generation Anti-obesity Medications: Comparisons, Questions, and Clinical Opportunities

Wadden, T. A., Chao, A. M., Moore, M., Tronieri, J. S., Gilden, A., Amaro, A., Leonard, S., & Jakicic, J. M. (2023) · Current Obesity Reports

Pharmacology and Obesity TreatmentObesity, Physical Activity, Diet

Cited by 129

Intensive Behavioral Therapy for Obesity Combined with Liraglutide 3.0 mg: A Randomized Controlled Trial

Wadden, T. A., Walsh, O. A., Berkowitz, R. I., Chao, A. M., Alamuddin, N., Gruber, K., Leonard, S., Mugler, K., Bakizada, Z., & Tronieri, J. S. (2019) · Obesity

Diabetes, Cardiovascular Risks, and LipoproteinsPharmacology and Obesity Treatment

Cited by 116

Correlates of Feeding Difficulties Among Children with Autism Spectrum Disorder: A Systematic Review

Page, S. D., Souders, M. C., Kral, T. V. E., Chao, A. M., & Pinto-Martin, J. (2022) · Journal of Autism and Developmental Disorders

Child Nutrition and Feeding IssuesAutism Spectrum Disorder Research

Cited by 114

Reducing youth screen time: Qualitative metasynthesis of findings on barriers and facilitators.

Minges, K. E., Owen, N., Salmon, J., Chao, A., Dunstan, D. W., & Whittemore, R. (2015) · Health Psychology

Child Development and Digital TechnologyPhysical Activity and Health

Cited by 109

Effects of Liraglutide and Behavioral Weight Loss on Food Cravings, Eating Behaviors, and Eating Disorder Psychopathology

Chao, A. M., Wadden, T. A., Walsh, O. A., Gruber, K. A., Alamuddin, N., Berkowitz, R. I., & Tronieri, J. S. (2019) · Obesity

Eating Disorders and BehaviorsPharmacology and Obesity Treatment

Cited by 84

A pilot randomized controlled trial of liraglutide 3.0 mg for binge eating disorder

Allison, K. C., Chao, A. M., Bruzas, M. B., McCuen‐Wurst, C., Jones, E., McAllister, C., Gruber, K., Berkowitz, R. I., Wadden, T. A., & Tronieri, J. S. (2023) · Obesity Science & Practice

Eating Disorders and BehaviorsPharmacology and Obesity Treatment

Cited by 75

Effects of liraglutide on appetite, food preoccupation, and food liking: results of a randomized controlled trial

Tronieri, J. S., Wadden, T. A., Walsh, O., Berkowitz, R. I., Alamuddin, N., Gruber, K., Leonard, S., Bakizada, Z. M., & Chao, A. M. (2020) · International Journal of Obesity

Pharmacology and Obesity TreatmentRegulation of Appetite and Obesity

Cited by 74

Clinical Insight on Semaglutide for Chronic Weight Management in Adults: Patient Selection and Special Considerations

Chao, A. M., Tronieri, J. S., Amaro, A., & Wadden, T. A. (2022) · Drug Design, Development and Therapy

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 58

General Life and Diabetes-Related Stressors in Early Adolescents With Type 1 Diabetes

Chao, A. M., Minges, K. E., Park, C., Dumser, S., Murphy, K. M., Grey, M., & Whittemore, R. (2016) · Journal of Pediatric Health Care

Diabetes Management and EducationDiabetes Management and Research

Cited by 54

Effects of addictive-like eating behaviors on weight loss with behavioral obesity treatment

Chao, A. M., Wadden, T. A., Tronieri, J. S., Pearl, R. L., Alamuddin, N., Bakizada, Z. M., Pinkasavage, E., Leonard, S. M., Alfaris, N., & Berkowitz, R. I. (2019) · Journal of Behavioral Medicine

Eating Disorders and BehaviorsNutrition, Health and Food Behavior

Cited by 48

Weight change 2 years after termination of the intensive lifestyle intervention in the Look AHEAD study.

Look AHEAD Research Group, Chao, A. M., Wadden, T. A., Berkowitz, R. I., Blackburn, G., Bolin, P., Clark, J. M., Coday, M., Curtis, J. M., Delahanty, L. M., et al. (2020) · Obesity

Diabetes, Cardiovascular Risks, and LipoproteinsObesity, Physical Activity, Diet

Cited by 40

The past, present, and future of behavioral obesity treatment

Chao, A. M., Moore, M., & Wadden, T. A. (2025) · International Journal of Obesity

Obesity, Physical Activity, DietPharmacology and Obesity Treatment

Cited by 40

Short‐ and Long‐Term Changes in Health‐Related Quality of Life with Weight Loss: Results from a Randomized Controlled Trial

Pearl, R. L., Wadden, T. A., Tronieri, J. S., Berkowitz, R. I., Chao, A. M., Alamuddin, N., Leonard, S. M., Carvajal, R., Bakizada, Z. M., Pinkasavage, E., et al. (2018) · Obesity

Pharmacology and Obesity TreatmentObesity, Physical Activity, Diet

Cited by 38

Effects of liraglutide plus phentermine in adults with obesity following 1 year of treatment by liraglutide alone: A randomized placebo-controlled pilot trial

Tronieri, J. S., Wadden, T. A., Walsh, O. A., Berkowitz, R. I., Alamuddin, N., Gruber, K., Leonard, S., & Chao, A. M. (2019) · Metabolism

Pharmacology and Obesity TreatmentRegulation of Appetite and Obesity

Cited by 29

The risk of cardiovascular complications with current obesity drugs

Chao, A. M., Wadden, T. A., Berkowitz, R. I., Quigley, K., & Silvestry, F. (2020) · Expert Opinion on Drug Safety

Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes

Cited by 23

Orforglipron for maintenance of body weight reduction: the double-blind, randomized phase 3b ATTAIN-MAINTAIN trial

Aronne, L. J., Horn, D. B., le Roux, C. W., Chao, A. M., Ho, W., Halpern, B., Griffin, R., Xie, C., Valderas, E. G., Lee, C. J., et al. (2026) · Nature Medicine

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 22

Measures of adherence as predictors of early and total weight loss with intensive behavioral therapy for obesity combined with liraglutide 3.0 mg

Tronieri, J. S., Wadden, T. A., Walsh, O., Berkowitz, R. I., Alamuddin, N., & Chao, A. M. (2020) · Behaviour Research and Therapy

Pharmacology and Obesity TreatmentObesity, Physical Activity, Diet

Cited by 21

Weight Change During the Postintervention Follow-up of Look AHEAD

Wing, R. R., Neiberg, R. H., Bahnson, J. L., Clark, J. M., Espeland, M. A., Hill, J. O., Johnson, K. C., Knowler, W. C., Olson, K., Steinburg, H., et al. (2022) · Diabetes Care

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 14

Intermittent Energy Restriction for Weight Loss: A Systematic Review of Cardiometabolic, Inflammatory and Appetite Outcomes

Wei, X., Cooper, A., Lee, I., Cernoch, C. A., Huntoon, G., Hodek, B., Christian, H., & Chao, A. M. (2022) · Biological Research For Nursing

Dietary Effects on HealthDiet and metabolism studies

Cited by 13